跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
备思复 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Enfortumab vedotin for Injection
Approved
生物制品
Enfortumab vedotin for Injection
ASTELLAS PHARMA EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Aug 13, 2024
Approval ID
8cp9TPOnyz0
Company
ASTELLAS PHARMA EUROPE B.V.
Type
生物制品
Approval Details
Approval Id
8cp9TPOnyz0
Approval Number
国药准字SJ20240034
Generic Name
注射用维恩妥尤单抗
Generic Name En
Enfortumab vedotin for Injection
Trade Name
备思复
Drug Type
生物制品
Dosage Form
注射剂
Strength
20 mg / 瓶
Reg Date
2024-08-13
Expired Date
2029-08-12
Company Name
ASTELLAS PHARMA EUROPE B.V.
Production Company Name
Baxter Oncology GmbH
Company Detail Path
/organization/astellas-pharma-europe-b-v
Production Company Detail Path
/organization/baxter-oncology-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 13, 2024
Approval ID
8cp9TPOnyz0
Type
生物制品
Back to NMPA Approvals